CERS6 and SPTLC2 were classified into a high-risk group with higher hazard ratios (HR > 1) and higher expression in tumor tissues, but S1PR1 exhibited a protective effect (HR < 1) and lower expression in malignant tissues. The gene discussed is SPTLC2; the disease is neoplasm.